Abstract
In the present study, we examined the effects of the agonists and antagonists of cholinergic receptors on central dopaminergic function using the 6-hydroxydopamine model of dopamine receptor supersensitivity. Unilateral lesioning of the substantia nigra with 6-hydroxydopamine was carried out in Wistar rats. Two weeks after surgery, the rats were tested for the presence of dopaminergic supersensitivity by their response to the dopamine receptor agonist, apomorphine. Apomorphine-induced rotations were significantly reinforced by the muscarinic receptor antagonist, atropine. In contrast to atropine, the muscarinic receptor agonist oxotremorine attenuated apomorphine's effects. Acute treatment of nicotine significantly reduced apomorphine-induced rotations. However, when increasing doses of nicotine were given for nine days, the rotations of the nicotine-dependent rats were significantly enhanced. So the fact that both muscarinic and nicotinic cholinergic activity could modulate apomorphine-induced rotations was readily apparent in these experiments.
References
Jun 1, 1990·Journal of Neurochemistry·R Bertorelli, S Consolo
Sep 18, 1990·Neuroscience Letters·C Le MoineB Bloch
Jun 1, 1990·Neuropharmacology·E FriedmanP Butkerait
Jan 1, 1989·Pharmacology, Biochemistry, and Behavior·Y K Fung, Y S Lau
Jun 9, 1987·Brain Research·Y KubotaM Tohyama
Sep 1, 1986·Pharmacology, Biochemistry, and Behavior·A MaitiL G Abood
Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Oct 1, 1986·International Clinical Psychopharmacology·T M Reilly, D H Batchelor
Apr 28, 1987·Brain Research·J J HaganA M van Delft
Apr 12, 1974·Nature·R J Miller, C R Hiley
Sep 1, 1973·Neuropharmacology·V H SethyM H Van Woert
Nov 1, 1983·Pharmacology, Biochemistry, and Behavior·D A WeldonK J Nicklaus
Apr 21, 1995·Neuroscience Letters·P P Rowell
Jan 1, 1993·Neuropharmacology·H Y WangB Weiss
Mar 1, 1993·Neurochemistry International·L W ZhouB Weiss
Citations
Apr 29, 2000·Schizophrenia Research·H E ShannonA Fink-Jensen
Aug 9, 2005·British Journal of Pharmacology·Yotam SagiMoussa B H Youdim
Aug 7, 2014·Molecular Neurobiology·Yan-Zhong GuanTian-Ming Gao
Oct 7, 1998·Neurochemistry International·Y SanvarindaP Govitrapong
May 11, 2021·Experimental Neurology·Zhihua LiuZhenguo Liu
Dec 7, 2013·BMC Neuroscience·Mathieu FavierMarc Savasta